Nanostructures based on monoolein or diolein and amphiphilic gadolinium complexes as MRI contrast agents

被引:10
|
作者
Accardo, Antonella [1 ]
Gianolio, Eliana [2 ,3 ,4 ]
Arena, Francesca [2 ,3 ,4 ]
Barnert, Sabine [5 ]
Schubert, Rolf [5 ]
Tesauro, Diego [1 ]
Morelli, Giancarlo [1 ]
机构
[1] Univ Naples Federico II, Dept Pharm, CIRPeB, I-80134 Naples, Italy
[2] Univ Naples Federico II, IBB CNR, I-80134 Naples, Italy
[3] Univ Turin, Dept Chem IFM, I-10125 Turin, Italy
[4] Univ Turin, Mol Imaging Ctr, I-10125 Turin, Italy
[5] Univ Freiburg, Dept Pharmaceut Technol & Biopharm, D-70104 Freiburg, Germany
关键词
LIQUID-CRYSTALLINE NANOPARTICLES; PROTON RELAXATION-TIMES; IN-VIVO; BIMODAL LIPOSOMES; SYSTEM; ATHEROSCLEROSIS; MACROPHAGES; MICROSCOPY; CONJUGATE; PARTICLES;
D O I
10.1039/c2tb00329e
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Highly ordered two or three dimensional mesophases in aqueous solution could be usefully obtained by using monoolein (MO) or diolein (DO) monomers. Nanostructures (also indicated as nanoparticles, NPs) of MO or DO containing different amounts (1%, 5%, 10% and 20%) of the synthetic amphiphilic gadolinium complex (C18)(2)DTPA(Gd) have been prepared and characterized for their relaxometric and structural behaviors. The nanostructure is found in the 110-200 nm range for all investigated systems, while the presence of the gadolinium containing monomer produces a partial loss of the cubic symmetry, as shown by Cryo-TEM images of NPs doped with 10% w/w of (C18)(2)DTPA(Gd). Gadolinium containing nanostructures display high relaxivity values (in the 10-15 mM(-1) s(-1) range at 25 degrees and 20 MHz, with a further increase at 37 degrees C for DO based NPs), and interesting relaxometric properties for their possible use as MRI contrast agents. NPs containing 10% w/w of (C18) 2DTPA(Gd) (MO3-NPs and DO3-NPs) have been also derivatized by introducing 3% wt of (C18)(2)-Peg(3000)-FA to obtain targeted aggregates (MO3-NP-FA, DO3-NP-FA). A preferential uptake efficiency of DO3-NP-FA in IGROV-1 cells with respect to DO-NPs without folic acid is observed, especially when cells are incubated with low concentrations of nanostructures or at short incubation times, thus indicating its potential use as a target-selective delivery system for MRI contrast agents on tumor cells overexpressing the folate receptor.
引用
收藏
页码:617 / 628
页数:12
相关论文
共 50 条
  • [1] Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents
    Yan, GP
    Hu, B
    Liu, ML
    Li, LY
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (03) : 351 - 357
  • [2] The gadolinium complexes with polyoxometalates as potential MRI contrast agents
    Li, Zhongfeng
    Li, Weisheng
    Li, Xiaojing
    Pei, Fengkui
    Li, Yingxia
    Lei, Hao
    MAGNETIC RESONANCE IMAGING, 2007, 25 (03) : 412 - 417
  • [3] Evaluation of dendritic gadolinium complexes as MRI contrast agents
    Yan, GP
    Bottle, SE
    Zhuo, RX
    Wei, L
    Liu, ML
    Li, LY
    JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2004, 19 (06) : 453 - 465
  • [4] Supramolecular aggregates of amphiphilic gadolinium complexes as blood pool MRI/MRA contrast agents:: Physicochemical characterization
    Vaccaro, Mauro
    Accardo, Antonella
    Tesauro, Diego
    Mangiapia, Gaetano
    Lof, David
    Schillen, Karin
    Soderman, Olle
    Morelli, Giancarlo
    Paduano, Luigi
    LANGMUIR, 2006, 22 (15) : 6635 - 6643
  • [5] Synthesis and physicochemical characterisation of new amphiphilic gadolinium DO3A complexes as contrast agents for MRI
    Glogård, C
    Hovland, R
    Fossheim, SL
    Aasen, AJ
    Klaveness, J
    JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 2000, 5 : 1047 - 1052
  • [6] Extracellular MRI contrast agents based on gadolinium
    Gries, H
    CONTRAST AGENTS I, 2002, 221 : 1 - 24
  • [7] Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents
    Gallo, Enrico
    Diaferia, Carlo
    Di Gregorio, Enza
    Morelli, Giancarlo
    Gianolio, Eliana
    Accardo, Antonella
    PHARMACEUTICALS, 2020, 13 (02)
  • [8] Gadolinium(III) complexes as MRI contrast agents:: ligand design and properties of the complexes
    Hermann, Petr
    Kotek, Jan
    Kubicek, Vojtech
    Lukes, Ivan
    DALTON TRANSACTIONS, 2008, (23) : 3027 - 3047
  • [9] Non-gadolinium-based MRI contrast agents
    Schwert, DD
    Davies, JA
    Richardson, N
    CONTRAST AGENTS I: MAGNETIC RESONANCE IMAGING, 2002, 221 : 165 - 199
  • [10] Gadolinium complexes of chlorin derivatives applicable for MRI contrast agents and PDT
    Galindev, Oyunbileg
    Dalantai, Monkhoobor
    Ahn, Woong Shick
    Shim, Young Key
    JOURNAL OF PORPHYRINS AND PHTHALOCYANINES, 2009, 13 (07) : 823 - 831